Targeting Robo4-Dependent Slit Signaling to Survive the Cytokine Storm in Sepsis and Influenza

Overview of attention for article published in Science Translational Medicine, March 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 1 news outlet
blogs: 2 blogs

patent: 9 patents
reddit: 2 Redditors

Readers on

mendeley: 217 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 9 patents that reference this research output.

SYNTHETIC PEPTIDE IS217 WITH DUAL ANTIMICROBIAL AND IMMUNOMODULATORY ACTIVITY FOR…

Application WO-2026053019-A1

World Intellectual Property Organisation (WIPO)

12 Mar 2026

USE OF THE RECOMBINANT FIBRINOGEN-LIKE DOMAIN OF ANGIOPOIETIN-LIKE 4 FOR TREATING SEPSIS…

Application WO-2025247922-A1

World Intellectual Property Organisation (WIPO)

04 Dec 2025

PEPTIDE WITH ANTI-INFLAMMATORY AND ANTI-MICROBIAL ACTIVITY

Application WO-2025093952-A1

World Intellectual Property Organisation (WIPO)

08 May 2025

SELECTIN OR GALECTIN ANTAGONISTS FOR TREATING CYTOKINE RELEASE SYNDROME AND CRS-INDUCED…

Application WO-2020150263-A1

World Intellectual Property Organisation (WIPO)

23 Jul 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 5 additional patents.